1 / 15

Provide end-to-end pharmaceuticals solutions

Provide end-to-end pharmaceuticals solutions. We Impart Health to Life. Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com. Corporate. Business Spread (Sales). Geographical Spread (Sales). 22%. 31%. 69% . 78% . API . Domestic Sales . Formulations. International Sales. Corporate.

lotus
Télécharger la présentation

Provide end-to-end pharmaceuticals solutions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Provide end-to-end pharmaceuticals solutions We Impart Health to Life Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com

  2. Corporate Business Spread (Sales) Geographical Spread (Sales) 22% 31% 69% 78% API Domestic Sales Formulations International Sales

  3. Corporate • Established 1978 • Rank 51 - IMS-ORG (India) • Rank 45 - Rx audit- CMARC • Exports to 95 countries • Competencies across the pharmaceutical value chain ORG Nov11/CMARC Jul-Oct11/AWACS Dec11

  4. API 110 Centaur House 230 Formulations Facilities 450 Sales Force 1150 CRO 60 Our assets- 2000 Centaurians

  5. Contract Manufacturing, Pune • Fully scalable formulations facility 25,000 square metres • Approved by USFDA, UK MHRA, TGA, Health Canada • Annual capacity 3 billion tablets & 600 million capsules • Formulations and Analytical R&D • On the anvil, Ophthalmics–12 million units pa www.centaurpharma.com We Impart Health to Life

  6. WHO-GMP Approved Formulations Facilities- Goa

  7. API, Ambernath • India's largest Psychotropic API player, introduced 28 API in India • USFDA / AFSSAPS approved • Proficiency- Conceptualisation to Commercialisation • Clientele: Big Pharma and generic majors

  8. Formulations Marketing • Exports to Asia, Americas, Africa • India- 50 million+ Rx annually • Brand leader in 6 therapy segments • 1145 Sales force, 10,000 Drs and 10,000 pharmacies daily 33Mn Rx / Year 1 Rx / Second

  9. Total Sales Force 1145

  10. Contract Research Fully integrated set-up- BA / BE / Clinical trials (Phase II/III) International standard CRO -10,000 sq.ft. 42 bed CPU, fully-equipped ICU Formulations & API development

  11. Strategic Alliances Strategy- Harness CRO, API & marketing proficiencies

  12. Strategic Alliances

  13. Contract Research API Contract Manufacturing Formulations Why Centaur • BA/BE studies • Clinical trials • R&D • USFDA/EU • API proficiencies • Pan India • 1145 Sales Force • 50,000,000 Rx • 250,000 Drs and pharmacies / month • USFDA/ UKMHRA/ TGA • World scale capacity

  14. Future Formulations Contract Research Contract Manufacturing API 2011 2016

  15. Contact Centaur Pharmaceuticals Pvt. Ltd. Centaur House, Vakola, Santacruz (E), Mumbai-400 055. INDIA Tel. : +91-22-6649 9100 Fax : +91-22-6649 9108 / 112 Website: www.centaurpharma.com Email: centaur@centaurlab.com

More Related